Myeloid IκBα deficiency promotes atherogenesis by enhancing leukocyte recruitment to the plaques

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Goossens, Pieter ^a   Vergouwe, Monique N ^a   Gijbels, Marion J J ^a   Curfs, Danielle M J ^a   van Woezik, Johannes H G ^a   Hoeksema, Marten A ^a   Xanthoulea, Sofia ^a   Leenen, Pieter J M ^b   Rupec, Rudolf A ^c   Hofker, Marten H ^d   de Winther, Menno P J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; RANTES; APOLIPOPROTEIN E; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW CELL; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE DELETION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ADHERENCE; MACROPHAGE; MOUSE; MOUSE STRAIN; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; ANIMAL; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CYTOLOGY; ENZYME IMMUNOASSAY; INFLAMMATION; LEUKOCYTE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

MUS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; CELL ADHESION; ENDOTHELIUM, VASCULAR; FEMALE; I-KAPPA B PROTEINS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; LEUKOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NF-KAPPA B; RECEPTORS, LDL;

EID: 79960652986     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022327     Document Type: Article

References (32)

1. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, et al. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11: 155-161.
2. Wiesner P, Choi SH, Almazan F, Benner C, Huang W, et al. (2010) Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ Res 107: 56-65.
3. Pahl HL, (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866.
4. Tergaonkar V, Correa RG, Ikawa M, Verma IM, (2005) Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. Nat Cell Biol 7: 921-923.
5. Karin M, Ben-Neriah Y, (2000) Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18: 621-663.
6. Vallabhapurapu S, Karin M, (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: 693-733.
7. de Winther MP, Kanters E, Kraal G, Hofker MH, (2005) Nuclear factor kappa B signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25: 904-914.
8. Hajra L, Evans AI, Chen M, Hyduk SJ, Collins T, et al. (2000) The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci U S A 97: 9052-9057.
9. Ross R, (1999) Atherosclerosis is an inflammatory disease. Am Heart J 138: S419-420.
10. Lusis AJ, (2000) Atherosclerosis. Nature 407: 233-241.
11. Brand K, Eisele T, Kreusel U, Page M, Page S, et al. (1997) Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol 17: 1901-1909.
12. Monaco C, Andreakos E, Kiriakidis S, Mauri C, Bicknell C, et al. (2004) Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci U S A 101: 5634-5639.
13. Xanthoulea S, Curfs DM, Hofker MH, de Winther MP, (2005) Nuclear factor kappa B signaling in macrophage function and atherogenesis. Curr Opin Lipidol 16: 536-542.
14. Brand K, Page S, Rogler G, Bartsch A, Brandl R, et al. (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97: 1715-1722.
15. Kanters E, Pasparakis M, Gijbels MJ, Vergouwe MN, Partouns-Hendriks I, et al. (2003) Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest 112: 1176-1185.
16. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, et al. (2008) Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab 8: 372-383.
17. Beg AA, Sha WC, Bronson RT, Baltimore D, (1995) Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev 9: 2736-2746.
18. Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, et al. (2006) Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 25: 6781-6799.
19. Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, et al. (1996) IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol 16: 2341-2349.
20. Rupec RA, Jundt F, Rebholz B, Eckelt B, Weindl G, et al. (2005) Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. Immunity 22: 479-491.
21. Chan J, Leenen PJ, Bertoncello I, Nishikawa SI, Hamilton JA, (1998) Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. Blood 92: 1423-1431.
22. Cook AD, Braine EL, Hamilton JA, (2003) The phenotype of inflammatory macrophages is stimulus dependent: implications for the nature of the inflammatory response. J Immunol 171: 4816-4823.
23. Yamamoto T, Naito M, Moriyama H, Umezu H, Matsuo H, et al. (1996) Repopulation of murine Kupffer cells after intravenous administration of liposome-encapsulated dichloromethylene diphosphonate. Am J Pathol 149: 1271-1286.
24. Tedgui A, Mallat Z, (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86: 515-581.
25. Wolfrum S, Teupser D, Tan M, Chen KY, Breslow JL, (2007) The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes. Proc Natl Acad Sci U S A 104: 18601-18606.
26. Zernecke A, Weber C, (2010) Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc Res 86: 192-201.
27. Zernecke A, Shagdarsuren E, Weber C, (2008) Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 28: 1897-1908.
28. Goossens P, Gijbels MJ, Zernecke A, Eijgelaar W, Vergouwe MN, et al. (2010) Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab 12: 142-153.
29. Leenen PJ, de Bruijn MF, Voerman JS, Campbell PA, van Ewijk W, (1994) Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods 174: 5-19.
30. Sunderkotter C, Nikolic T, Dillon MJ, Van Rooijen N, Stehling M, et al. (2004) Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 172: 4410-4417.
31. Natoli G, Chiocca S, (2008) Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation. Sci Signal 1: pe1.
32. Rebholz B, Haase I, Eckelt B, Paxian S, Flaig MJ, et al. (2007) Crosstalk between keratinocytes and adaptive immune cells in an IkappaBalpha protein-mediated inflammatory disease of the skin. Immunity 27: 296-307.